Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the diabetic retinopathy screening service for Wales: Retrospective analysis

BMJ (Online)

Volumn 344, Issue 7848, 2012, Pages

  Thomas, R L ^a   Dunstan, F ^b   Luzio, S D ^c   Roy Chowdury, S ^a   Hale, S L ^a   North, R V ^b   Gibbins, R L ^d   Owens, D R ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c SWANSEA UNIVERSITY   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULOPATHY; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; SEX DIFFERENCE; SURVIVAL RATE; UNITED KINGDOM; EARLY DIAGNOSIS; HOSPITALIZATION; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PATIENT REFERRAL; STATISTICS; SURVIVAL; TIME;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; INCIDENCE; INSULIN; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS; WALES;

EID: 84858414156     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e874     Document Type: Article

References (41)

1. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999-2000. Eye 2008;22:905-11.
2. Diabetic Retinopathy Study. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse effects to retinopathy severity. Study report no 5. Dev Ophthalmol 1981;2:248-61.
3. Early Treatment Diabetic Retinopathy Research Study Group. Photocoagulation for diabetic macular edema. Study report no 1. Arch Ophthalmol 1985;103:1796-806.
4. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976;81:383-96.
5. James M, Turner DA, Broadbent DM, Vora J, Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ 2000;320:1627-31. (Pubitemid 30364631)
6. Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 2000;283:889-96. (Pubitemid 30102129)
7. Burnett S, Hurwitz B, Davey C, Ray J, Chaturvedi N, Salzmann J, et al. The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study. Diabet Med 1998;15(suppl 3):S38-43.
8. Leese GP, Morris AD, Olson J. A national retinal screening programme for diabetes in Scotland. Diabet Med 2003;20:962-4. (Pubitemid 41701476)
9. Buxton MJ, Sculpher MJ, Ferguson BA, Humphreys JE, Altman JF, Spiegelhalter DJ, et al. Screening for treatable diabetic retinopathy: a comparison of different methods. Diabet Med 1991;8:371-7.
10. Chia DS, Yap EY. Comparison of the effectiveness of detecting diabetic eye disease: diabetic retinal photography versus ophthalmic consultation. Singapore Med J 2004;45:276-9. (Pubitemid 38843336)
11. Jones D, Dolben J, Owens DR, Vora JP, Young S, Creagh FM. Non-mydriatic Polaroid photography in screening for diabetic retinopathy: evaluation in a clinical setting. BMJ 1988;296:1029-30.
12. Owens DR, Gibbins RL, Lewis PA, Wall S, Allen JC, Morton R. Screening for diabetic retinopathy by general practitioners: ophthalmoscopy or retinal photography as 35 mm colour transparencies? Diabet Med 1998;15:170-5. (Pubitemid 28096286)
13. Scanlon PH, Malhotra R, Greenwood RH, Aldington SJ, Foy C, Flatman M, et al. Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. Br J Ophthalmol 2003;87:1258-63. (Pubitemid 37193918)
14. Baeza M, Orozco-Beltran D, Gil-Guillen VF, Pedrera V, Ribera MC, Pertusa S, et al. Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate? Int J Clin Pract 2009;63:433-8.
15. Aptel F, Denis P, Rouberol F, Thivolet C. Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. Diabet Metab 2008;34:290-3.
16. Benbassat J, Polak BC. Reliability of screening methods for diabetic retinopathy. Diabet Med 2009;26:783-90.
17. Hutchinson A, McIntosh A, Peters J, O'Keeffe C, Khunti K, Baker R, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy - a systematic review. Diabet Med 2000;17:495-506. (Pubitemid 30660150)
18. British Diabetic Association. Retinal photography screening for diabetic eye disease. A British Diabetic Association report. British Diabetic Association, 1997.
19. Garvican L, Clowes J, Gillow T. Preservation of sight in diabetes: developing a national risk reduction programme. Diabet Med 2000;17:627-34.
20. Harding S, Greenwood R, Aldington S, Gibson J, Owens DR, Taylor R, et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003;20:965-71. (Pubitemid 41701477)
21. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabet Res Clin Pract 2010;87:4-14.
22. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiology Study of Diabetic Retinopathy. XV: the long term incidence of macular edema. Ophthalmology 1995;102:7-16.
23. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiology Study of Diabetic Retinopathy. XXIII: the twenty-five year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009;116:497-503.
24. Kyto JP, Harjutsalo V, Forsblom C, Hietala K, Summanen PA, Groop PH, et al. Decline in the cumulative incidence of server diabetic retinopathy in patients with type 1 diabetes. Diabetes Care 2011;34:2005-7.
25. Olafsdottir E, Stefansson E. Biennial eye screening in diabetic patients without retinopathy. 10 year experience. Br J Ophthalmol 2007;91:1599-601. (Pubitemid 350207380)
26. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye study: a cohort study. Lancet 2003;361:195-200. (Pubitemid 36126218)
27. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in type 1 diabetes in a systematic screening programme. Diabet Med 2003;20:758-65. (Pubitemid 41701472)
28. Misra A, Bachmann MO, Greenwood RH, Jenkins C, Shaw A, Barakat O, et al. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 2009;26:1040-7.
29. Agardh E, Tababat-Khani P. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 2011;34:1318-9.
30. English National Screening Progamme - Diabetic Retinopathy (ENSPDR). Exclusions: excluding patients from the NHS diabetic retinopathy screening programme temporarily or permanently. ENSPDR, 2006.
31. Efron B, Tibshirani J. An introduction to the bootstrap . CRC Press, 1994.
32. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974;19:716-23.
33. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X: four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989;107:244-9. (Pubitemid 19055345)
34. Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye 2007;21:465-71. (Pubitemid 46564136)
35. Leske M, Wu S, Hennis A, Nemesure B, Hyman L, Schachat A. Incidence of diabetic retinopathy in the Barbados eye studies. Ophthalmology 2003;110:941-7. (Pubitemid 36560493)
36. Leske M, Wu S, Hennis A, Nemesure B, Schachat A, Hyman L, et al. Nine-year incidence of diabetic retinopathy in the Barbados eye studies. Arch Ophthalmol 2006;124:250-5. (Pubitemid 43247076)
37. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-63. (Pubitemid 32156199)
38. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:88-93. (Pubitemid 36897941)
39. The Breast Screening Frequency Trial Group. The frequency of breast screening: results from the UKCCCR randomised trial. Eur J Cancer 2002;38:1458-64.
40. Levin B. Colorectal cancer screening: sifting through the evidence. J Natl Cancer Inst 1999;91:400.
41. American Diabetes Association. American Diabetes Association: clinical practice recommendations. Diabetes Care 2010;33(suppl 1):S11-61.